🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchFLOW trial: semaglutide renal outcomes — need advice Page 6

FLOW trial: semaglutide renal outcomes — need advice

Dr.PainCLE Thu, Apr 16, 2026 at 9:08 PM 30 replies 843 viewsPage 6 of 6
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
May 8, 2026 at 1:48 AM#26
PharmacoVig_BOS said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

46 21mike_mealprep, NicoleRaleigh, james_edin and 43 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 10, 2026 at 9:07 AM#27
PharmacoVig_BOS said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

This is exactly what I could not find anywhere else.

Last edited: May 10, 2026 at 1:07 PM
45 20ChrisMacros, KetoKyle, CanadaChris and 42 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
May 12, 2026 at 4:27 PM#28

Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Ask again with the specifics and you will get a better answer than this one.

44 19Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 41 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
May 14, 2026 at 11:48 PM#29
Dr.BariatricHTX said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This matches mine closely enough to be worth saying so out loud.

43 18TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 40 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
May 17, 2026 at 7:11 AM#30

Closing the loop on my own question.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

Last edited: May 17, 2026 at 10:11 AM
21 21amy_econ_NJ, bbq_ray_KC, oliver_london and 18 others
Reply Quote Save Share Report
1456

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register